The case for an integrative model: Hypotheses and rationale for integrative MDMA-Assisted Psychotherapy (IMAP)

The original MAPS manual for MDMA-assisted therapy (MDMA-AT) opened a therapeutic frontier for PTSD. However, it drew critique for concepts—such as “inner healing intelligence” – that originated in transpersonal traditions rather than academic or empirically grounded clinical models. While many patients found the therapies helpful, these constructs were difficult to interpret and standardize. They lacked a clear foundation in trauma science, making them challenging to integrate into mainstream clinical practice. In response, we propose Integrative MDMA-Assisted Psychotherapy (IMAP), a principle-guided, patient-driven model rooted in both humanistic and trauma-focused psychotherapy traditions. IMAP diverges from directive, technique-centered psychotherapy models by offering a flexible, relationally attuned approach that supports the nonlinear, emergent processes characteristic of MDMA-assisted therapy. This flexibility is grounded in orienting principles that enable clinicians to make real-time decisions without relying on a predetermined agenda. IMAP incorporates contemporary theories of PTSD and selectively draws from evidence-based trauma interventions, while retaining the ethos of experiential approaches. Its divergence from both protocol-driven PTSD treatments and atheoretical, non-directive psychedelic models invites empirical investigation to identify which therapeutic elements are essential in psychedelic contexts.